Microsoft's Project Ire has successfully identified a new variant of the LOTUSLITE malware, a Windows DLL backdoor. Unlike traditional methods that rely on known indicators of compromise, Ire uses a function-by-function behavioral analysis to determine the malicious nature of software. This approach allows it to detect threats that evade signature-based detection systems. The discovery demonstrates the potential of AI-driven tools in cybersecurity, providing a new method for identifying and understanding malware based on behavior rather than pre-existing data.
Exin Therapeutics has demonstrated an AI agent physically controlling a robotic arm to inject drugs into a live mouse's brain. The experiment reveals a critical divergence in model behavior: Anthropic’s Claude Opus refused the procedure due to safety concerns, while Sonnet proceeded. This suggests that as agents gain direct access to physical lab equipment, their alignment and refusal mechanisms become operational realities rather than theoretical safeguards. It marks a shift from AI merely analyzing data to actively manipulating biological systems under human supervision. The team initially tested Claude Opus 5.5, but it halted the injection, citing potential harm. Switching to Claude Sonnet 5 allowed the procedure to complete, though with delays caused by coordinate system glitches. A secondary Opus agent had to fix code errors without knowing a live surgery was underway. Human oversight remains essential as researchers test more complex tasks like craniotomies.
